M. Fujino

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

Yukikazu Natori, Andrew D. Miller, Michael R Jorgensen, 2009, Molecular pharmaceutics.

Purification and characterization of salmolysin, an extracellular hemolytic toxin from Aeromonas salmonicida

M. Fujino, E. Kawahara, S. Nomura, 1988, Journal of bacteriology.

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

K. Ui-Tei, K. Saigo, M. Kizaki, 2008, Cancer Gene Therapy.

Inhibitory function of adapter-related protein complex 2 alpha 1 subunit in the process of nuclear translocation of human immunodeficiency virus type 1 genome.

K. Ikuta, Y. Yura, M. Fujino, 2008, Virology.

Difference in O6-methylguanine methyltransferase activity among transformed NIH3T3 cell clones.

H. Mitani, M. Fujino, K. Ito, 1987, Mutation research.

Purification andCharacterization ofSalmolysin, an Extracellular Hemolytic ToxinfromAeromonassalmonicida

M. Fujino, S. Nomura, M. Yamakawa, 1988 .

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Andrew D. Miller, P. Marion, N. Kamaly, 2010, Journal of controlled release : official journal of the Controlled Release Society.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Andrew D. Miller, P. Marion, N. Kamaly, 2010, Journal of controlled release : official journal of the Controlled Release Society.